Hims & Hers Health Inc HIMS

Healthcare

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. It offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.

NYSE:HIMS - Post by User

Hims & Hers Health Inc

<< Previous

Bullboard Posts

Next >>

Post by BalanceBeam17y8on Nov 27, 2024 7:33am

25 Views

Post# 36333002

FDA Drama Could Be a Game-Changer!

The FDA playing ping-pong with drug shortage statuses is actually bullish AF for HIMS. Compounded meds are their bread and butter right now. If Lilly’s GLP-1 drugs stay on the “shortage” list, HIMS is gonna ride that wave hard. Feels like a perfect setup for near-term upside. Thoughts on whether the FDA will flip-flop again?

<< Previous

Bullboard Posts

Next >>

AI companies to invest in